Sandbox:DD HA: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 20: | Line 20: | ||
* [[Normocytic anemia|Normocytic]] (80-100 femtoliter) | * [[Normocytic anemia|Normocytic]] (80-100 femtoliter) | ||
| | | | ||
* Indirect hyperbilirubinemia | * Indirect [[hyperbilirubinemia]] | ||
* Reticulocytosis | * [[Reticulocytosis]] | ||
* Low haptoglobin | * Low [[haptoglobin]] | ||
* Elevated LDH | * Elevated [[LDH]] | ||
| | | | ||
* Pallor | * [[Pallor]] | ||
* Jaundice | * [[Jaundice]] | ||
| | | | ||
* Removal of offending agent | * Removal of offending agent | ||
* Steroids | * [[Steroids]] | ||
* Alternative immunosuppression | * Alternative [[immunosuppression]] | ||
| | | | ||
* HELLP syndrome | * [[HELLP syndrome]] | ||
* TTP | * [[TTP]] | ||
* CLL | * [[Chronic lymphocytic leukemia|CLL]] | ||
|- | |- | ||
|[[Sideroblastic anemia]] | |[[Sideroblastic anemia]] | ||
Line 48: | Line 48: | ||
* [[Normocytic anemia|Normocytic]] (80-100 femtoliter) | * [[Normocytic anemia|Normocytic]] (80-100 femtoliter) | ||
| | | | ||
* Ringed sideroblasts in bone marrow | * Ringed sideroblasts in [[bone marrow]] | ||
* Low vitamin B6 level | * Low [[vitamin B6]] level | ||
* High lead level | * High [[lead]] level | ||
| | | | ||
* Pallor | * [[Pallor]] | ||
* Weakness | * [[Muscle weakness|Weakness]] | ||
| | | | ||
* Removal of offending medication | * Removal of offending [[medication]] | ||
* High-dose vitamin B6 (up to 200mg daily) | * High-dose [[vitamin B6]] (up to 200mg daily) | ||
* Avoidance of splenectomy | * Avoidance of [[splenectomy]] | ||
* Symptomatic transfusion support with iron chelation as needed | * Symptomatic [[Blood transfusion|transfusion]] support with [[iron]] [[chelation]] as needed | ||
| | | | ||
* Myelodysplastic syndrome | * [[Myelodysplastic syndrome]] | ||
* Myeloproliferative neoplasm | * [[Myeloproliferative neoplasm]] | ||
* Iron overload | * [[Iron overload]] | ||
|- | |- | ||
|[[Anemia of chronic disease]] | |[[Anemia of chronic disease]] | ||
Line 75: | Line 75: | ||
* [[Normocytic anemia|Normocytic]] (80-100 femtoliter) | * [[Normocytic anemia|Normocytic]] (80-100 femtoliter) | ||
| | | | ||
* Elevated ESR and CRP | * Elevated [[ESR]] and [[CRP]] | ||
* Elevated hepcidin | * Elevated [[hepcidin]] | ||
* Low serum iron | * Low serum [[iron]] | ||
* Low transferrin | * Low [[transferrin]] | ||
* Elevated ferritin | * Elevated [[ferritin]] | ||
| | | | ||
* Pallor | * [[Pallor]] | ||
* Weakness | * [[Weakness]] | ||
| | | | ||
* Treatment of the underlying cause; erythropoiesis-stimulating agents | * Treatment of the underlying cause; [[erythropoiesis]]-stimulating agents | ||
* Supportive red blood cell transfusions | * Supportive [[Red blood cell transfusion|red blood cell transfusions]] | ||
| | | | ||
* Inflammatory bowel disease | * [[Inflammatory bowel disease]] | ||
|- | |- | ||
|[[Thalassemia]] | |[[Thalassemia]] | ||
Line 96: | Line 96: | ||
* [[Microcytic]] (<80 femtoliter) | * [[Microcytic]] (<80 femtoliter) | ||
| | | | ||
* Abnormal hemoglobin electrophoresis (in beta-thalassemia) | * Abnormal [[hemoglobin]] [[electrophoresis]] (in [[beta-thalassemia]]) | ||
| | | | ||
* Irritability | * [[Irritability]] | ||
* Growth retardation | * [[Growth retardation]] | ||
* Jaundice | * [[Jaundice]] | ||
* Hepatomegaly | * [[Hepatomegaly]] | ||
* Splenomegaly | * [[Splenomegaly]] | ||
| | | | ||
* Transfusion support | * [[Blood transfusion|Transfusion]] support | ||
* Iron chelation | * [[Iron]] chelation | ||
* Gene therapy if available | * [[Gene therapy]] if available | ||
| | | | ||
* Extramedullary hematopoiesis | * [[Extramedullary hematopoiesis]] | ||
|- | |- | ||
|[[Iron deficiency anemia]] | |[[Iron deficiency anemia]] | ||
Line 116: | Line 116: | ||
* [[Microcytic]] (<80 femtoliter) | * [[Microcytic]] (<80 femtoliter) | ||
| | | | ||
* Low serum iron | * Low serum [[iron]] | ||
* Elevated transferrin | * Elevated [[transferrin]] | ||
* Low transferrin saturation | * Low [[transferrin saturation]] | ||
* Low ferritin | * Low [[ferritin]] | ||
| | | | ||
* Pallor | * [[Pallor]] | ||
* Weakness | * [[Weakness]] | ||
* Positive occult blood testing (if GI bleeding) | * Positive [[occult blood]] testing (if [[Gastrointestinal bleeding|GI bleeding]]) | ||
| | | | ||
* Intravenous or oral iron supplementation | * Intravenous or oral iron supplementation | ||
| | | | ||
* Chronic blood loss | * [[Blood loss|Chronic blood loss]] | ||
|- | |- | ||
|[[Erythropoietin]] deficiency | |[[Erythropoietin]] deficiency | ||
Line 137: | Line 137: | ||
* [[Normocytic anemia|Normocytic]] (80-100 femtoliter) | * [[Normocytic anemia|Normocytic]] (80-100 femtoliter) | ||
| | | | ||
* Low erythropoietin level | * Low [[Erythropoietin|erythropoietin level]] | ||
| | | | ||
* Pallor | * [[Pallor]] | ||
* Weakness | * [[Weakness]] | ||
* Signs of chronic kidney disease | * Signs of [[chronic kidney disease]] | ||
| | | | ||
* Epoetin alfa 50-100 units/kg 3 times weekly | * [[Epoetin alfa]] 50-100 units/kg 3 times weekly | ||
* Darbepoietin 0.45 mcg/kg weekly or 0.75 mcg/kg every 2 weeks | * Darbepoietin 0.45 mcg/kg weekly or 0.75 mcg/kg every 2 weeks | ||
| | | | ||
* Dialysis dependence | * [[Dialysis]] dependence | ||
* Myelodysplastic syndrome | * [[Myelodysplastic syndrome]] | ||
|- | |- | ||
|[[Vitamin B12 deficiency|Vitamin B12]] or [[folate deficiency]] | |[[Vitamin B12 deficiency|Vitamin B12]] or [[folate deficiency]] | ||
Line 159: | Line 159: | ||
| | | | ||
* Low vitamin B12 or folate level | * Low vitamin B12 or folate level | ||
* Megaloblastic anemia with hypersegmented neutrophils | * [[Megaloblastic anemia]] with hypersegmented [[neutrophils]] | ||
| | | | ||
* Numbness | * [[Numbness]] | ||
* Weakness | * [[Weakness]] | ||
* Tingling | * [[Tingling]] | ||
* Paresthesias | * [[Paresthesias]] | ||
| | | | ||
* Vitamin B12 1000mcg daily | * [[Vitamin B12]] 1000mcg daily | ||
* Folate 1mg daily | * [[Folate]] 1mg daily | ||
| | | | ||
* Neuropathy | * [[Neuropathy]] | ||
|} | |} |
Latest revision as of 20:23, 31 October 2017
DD of hemolytic anemia
Characterisitc/Parameter | Etiology | Mean corpuscular volume | Laboratory abnormalities | Physical examination | Treatment | Other associated abnormalities |
---|---|---|---|---|---|---|
Hemolytic anemia |
|
|
|
|
||
Sideroblastic anemia |
Or
|
|
|
|||
Anemia of chronic disease |
|
|
|
|||
Thalassemia |
|
|
|
|
||
Iron deficiency anemia |
|
|
|
|
|
|
Erythropoietin deficiency |
|
|
|
|
| |
Vitamin B12 or folate deficiency |
|
|
|